Clinical trial

Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder

NCT01798914

StatusNO_LONGER_AVAILABLE

Study typeEXPANDED_ACCESS

Start date2008-10-01

PhaseN/A

Study timeline

Study start (unknown)2008-10-01Date precision: month

Registry last updated2016-01-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Type 2 Diabetesunresolved

Interventions

Technosphere Insulin Inhalation PowderDRUG

Sponsors & collaborators

Mannkind Corporationlead sponsor

Mapped research locations

MiamiFlorida, United States1 ShreveportLouisiana, United States1 AshevilleNorth Carolina, United States1 New Hyde ParkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01798914 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.